An Investigation into Cell-Free DNA in Different Common Cancers

被引:2
|
作者
Nafar, Samira [1 ]
Hosseini, Kamran [2 ]
Shokrgozar, Negin [3 ]
Farahmandi, Amir Yousef [4 ]
Alamdari-Palangi, Vahab [2 ]
Sichani, Ali Saber [5 ]
Fallahi, Jafar [2 ]
机构
[1] Shiraz Univ Med Sci, Dept Med Genet, Shiraz 7135768748, Iran
[2] Shiraz Univ Med Sci, Sch Adv Med Sci & Technol, Dept Mol Med, Shiraz, Iran
[3] Shiraz Univ Med Sci, Hematol Res Ctr, Shiraz, Iran
[4] Shiraz Univ Med Sci, Dept English, Shiraz, Iran
[5] Texas A&M Univ, Dept Biol, College Stn, TX 77843 USA
关键词
Cell-free DNA; Cancer; Biomarker; CIRCULATING TUMOR DNA; DROPLET DIGITAL PCR; MULTIPLE-MYELOMA; RESIDUAL DISEASE; PLASMA; LYMPHOMA; DIAGNOSIS; BIOMARKER; STATISTICS; MUTATIONS;
D O I
10.1007/s12033-023-00976-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Diagnosis is the most important step in different diseases, especially in cancers and blood malignancies. There are different methods in order to better diagnose of cancer, but many of them are invasive and also, some of them are not useful for immediate diagnosis. Cell-free DNA (cfDNA) or liquid biopsy easily accessible in peripheral blood is one of the non-invasive prognostic biomarkers in various areas of cancer management. In fact, amounts of cfDNA in serum or plasma can be used for diagnosis. In this review, we have considered some cancers such as hepatocellular carcinoma, lung cancer, breast cancer, and hematologic malignancies to compare the various methods of cfDNA diagnosis. The result of early diagnosis along with correct treatment decreases morbidity.Cell-free DNA is a non-invasive way of diagnosing the presence of tumor cells in earlier stages of cancer.DNA released from both solid tumors and hematologic malignancies is usable in this method.Genetic feature of cancer cells at different stages can help in prescribing the amount and type of drugs.
引用
收藏
页码:3462 / 3474
页数:13
相关论文
共 50 条
  • [41] Detecting Cancer by Cell-free DNA
    不详
    CANCER DISCOVERY, 2013, 3 (02) : 129 - 130
  • [42] Cell-Free DNA in Hematologic Malignancies
    Schroers-Martin, Joseph G.
    Alizadeh, Ash A.
    JCO ONCOLOGY PRACTICE, 2024, 20 (11)
  • [43] Advances in Cell-Free DNA Screening
    Pertile, M.
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2019, 59 : 112 - 113
  • [44] Cell-Free DNA in Dermatology Research
    Wiggins, Jennifer M.
    Ali, Saim
    Polsky, David
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2022, 142 (06) : 1523 - +
  • [45] Phenotypes from cell-free DNA
    Zukowski, Alexis
    Rao, Satyanarayan
    Ramachandran, Srinivas
    OPEN BIOLOGY, 2020, 10 (09)
  • [46] Cell-Free DNA in Ischemic Stroke
    Falcione, Sarina R.
    Jickling, Glen C.
    STROKE, 2022, 53 (04) : 1245 - 1246
  • [47] Cell-free DNA Comparison of Technologies
    Dar, Pe'er
    Shani, Hagit
    Evans, Mark I.
    CLINICS IN LABORATORY MEDICINE, 2016, 36 (02) : 199 - +
  • [48] Cell-free DNA as a biomarker of aging
    Teo, Yee Voan
    Capri, Miriam
    Morsiani, Cristina
    Pizza, Grazia
    Caetano Faria, Ana Maria
    Franceschi, Claudio
    Neretti, Nicola
    AGING CELL, 2019, 18 (01)
  • [49] Sizing Up Cell-Free DNA
    Quake, Stephen
    CLINICAL CHEMISTRY, 2012, 58 (03) : 489 - 490
  • [50] Cell-Free DNA as an Obesity Biomarker
    Camuzi Zovico, Paulo Vinicios
    Gasparini Neto, Victor Hugo
    Venancio, Fernanda Ambrim
    Soares Miguel, Gustavo Peixoto
    Grace Pedrosa, Rogerio
    Kenji Haraguchi, Fabiano
    Barauna, Valerio G.
    PHYSIOLOGICAL RESEARCH, 2020, 69 (03) : 515 - 520